OPKO homes in on POC diagnostics with Claros buy
This article was originally published in Clinica
Executive Summary
OPKO Health has increased its footprint in the in vitro testing market by purchasing Claros Diagnostics, which is developing point-of-care blood tests for urology and infectious diseases. Financial terms of the deal were not disclosed.